Diana Hausman
Chief Tech/Sci/R&D Officer at ZENTALIS PHARMACEUTICALS, INC.
Net worth: 4 M $ as of 2024-04-29
Profile
Diana F.
Hausman is currently an Independent Director at Immuneering Corp., a Member of the American Society of Clinical Oncology, Inc., a Member of the American Society of Hematology, and the Chief Medical Officer at Zentalis Pharmaceuticals, Inc. She previously worked as a Senior Associated Medical Director at Berlex, Inc., a Senior Director-Clinical Research at ZymoGenetics, Inc., the Chief Medical Officer at Zymeworks BC, Inc., the Chief Medical Officer at Cascadian Therapeutics LLC, the Chief Medical Officer at Lengo Therapeutics, Inc., the Chief Medical Officer at Link Immunotherapeutics, Inc., and the Chief Medical Officer at Zymeworks, Inc. Dr. Hausman holds a doctorate degree from the University of Pennsylvania and an undergraduate degree from Princeton University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-05-08 | 373,876 ( 0.53% ) | 4 M $ | 2024-04-29 | |
2024-04-17 | 0 ( -.--% ) | - $ | 2024-04-29 |
Diana Hausman active positions
Companies | Position | Start |
---|---|---|
IMMUNEERING CORPORATION | Director/Board Member | 2022-01-17 |
ZENTALIS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2024-01-18 |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Corporate Officer/Principal | - |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Corporate Officer/Principal | - |
Former positions of Diana Hausman
Companies | Position | End |
---|---|---|
Link Immunotherapeutics, Inc.
Link Immunotherapeutics, Inc. Medical/Nursing ServicesHealth Services Link Immunotherapeutics, Inc. is a holding company, which engages in combination therapies. Its biotechnology is dual biscpecifics. The company was founded in 2019 and is headquartered in Seattle, WA. | Chief Tech/Sci/R&D Officer | 2023-09-30 |
Lengo Therapeutics, Inc.
Lengo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lengo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Menlo Park, CA. | Chief Tech/Sci/R&D Officer | 2022-02-28 |
ZYMEWORKS INC. | Chief Tech/Sci/R&D Officer | 2021-05-14 |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Chief Tech/Sci/R&D Officer | 2021-04-14 |
CASCADIAN THERAPEUTICS INC (USA) | Chief Tech/Sci/R&D Officer | 2016-03-31 |
Training of Diana Hausman
Princeton University | Undergraduate Degree |
University of Pennsylvania | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
IMMUNEERING CORPORATION | Health Technology |
ZYMEWORKS INC. | Health Technology |
ZENTALIS PHARMACEUTICALS, INC. | Health Technology |
Private companies | 8 |
---|---|
Cascadian Therapeutics LLC
Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Cascadian Therapeutics LLC is a clinical-stage biopharmaceutical company, which focuses on the development of therapeutic products for the treatment of cancer. Its product ONT-380, is an orally active and selective small-molecule HER2 inhibitor. The firm also develops preclinical product candidates in oncology using Chk1 kinase inhibitor and protocell technology. The company was founded on September 7, 2007 and is headquartered in Bothell, WA. | Health Technology |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
Berlex, Inc.
Berlex, Inc. Pharmaceuticals: MajorHealth Technology Berlex, Inc. manufactured pharmaceutical company. It developed novel diagnostics and therapeutics, which address unmet medical needs. It used to researches, develops, manufactures and markets ethical pharmaceuticals in five strategic areas such as female healthcare, diagnostic imaging, dermatology, oncology and therapeutics. The company was headquartered in Wayne, NJ | Health Technology |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
Lengo Therapeutics, Inc.
Lengo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lengo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Menlo Park, CA. | Health Technology |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Commercial Services |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Health Services |
Link Immunotherapeutics, Inc.
Link Immunotherapeutics, Inc. Medical/Nursing ServicesHealth Services Link Immunotherapeutics, Inc. is a holding company, which engages in combination therapies. Its biotechnology is dual biscpecifics. The company was founded in 2019 and is headquartered in Seattle, WA. | Health Services |
- Stock Market
- Insiders
- Diana Hausman